Vitasharm

General characteristics. Structure:

Active ingredients: Retinolum acetate of 5.68 mg (16500 ME), Thiamini chloridum of 5 mg, Riboflavinum of 5 mg, calcium антотенат 10 mg, pyridoxine hydrochloride of 5 mg, niacinamide of 50 mg; 30 pieces in packaging. Tablets of white color with a specific smell. On cross section two layers are visible: internal — yellow-orange color.

Pharmacological properties:

The polyvitaminic drug containing vitamins of groups A and B which pharmacological effect is caused by properties of the vitamins which are its part. Vitasharm promotes improvement of blood supply of skin, recovers its elasticity and elasticity, protects skin from the damaging action of Uv-radiation and harmful effects of the environment. Maintains the normal state of hair, nails, an epithelium of mucous membranes. Vitasharm has antiinflammatory, antioxidant effect, slows down aging processes.

Indications to use:

Prevention and treatment hypo - and avitaminosis; in complex therapy of skin diseases (eczema, psoriasis, an ichthyosis, a hyperkeratosis).

Route of administration and doses:

Before an initiation of treatment — to consult with the doctor. Vitasharm accept inside after food on 1 tablet a day. A course of treatment — 30 days. Repeated courses — according to the recommendation of the doctor.

Features of use:

Coloring of urine in yellow color is possible that is explained by existence in Riboflavinum drug (Vit. B2).

Side effects:

Allergic reactions to drug components are possible.

Contraindications:

Hypersensitivity to drug components. Pregnancy, cholelithiasis, chronic pancreatitis. A concomitant use with other polyvitaminic drugs (in order to avoid overdose).

Storage conditions:

In the dry, protected from light place. To store in the places unavailable to children. Period of validity 2 years. Not to use after the term specified on packaging.

Issue conditions:

Without recipe

Packaging:

On 30 or 50 tablets in banks of orange glass either in banks polymeric or in bottles polymeric. On 10 tablets in a blister strip packaging. Each can or a bottle, on 3 or 5 blister strip packagings together with  the application instruction place in a pack from a cardboard. Banks polymeric or bottles polymeric without packs with the equal number of application instructions or supplied with the glue application instruction place in group packaging.